Agenus | AGEN - Passifs Courants





Passifs Courants Changement Date
AbbVie USD 41.64B 458M 2026-06
Agenus USD 231.82M 17.42M 2026-06
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Celldex Therapeutics USD 61.32M 9.85M 2026-06
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 47.74B 11.11B 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Glaxosmithkline GBP 22.43B 6.39B 2026-03
Incyte USD 1.31B 177.55M 2026-06
Intrexon USD 23.02M 38K 2024-06
J&J USD 54.9B 2.82B 2026-06
Jiangsu Hengrui CNY 5.64B 732.51M 2026-03
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
Merck EUR 8.12B 1.22B 2026-06
Merck USD 27.73B 786M 2026-06
Northwest Biotherapeutics USD 82.97M 4.93M 2026-03
Novartis USD 31.75B 374M 2026-06
Novavax USD 330.57M 11.89M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 62.74M 6.62M 2026-06